Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
| Issued: 19 July 2007 at 15:00 |
Ref: MDA/2007/058
|
|
|
Immediate action |
|
Action |
|
|
Update |
|
|
Information request |
| Device: Point of care and home-use blood glucose meters: Roche Accu-Chek and Glucotrend; Abbott Diabetes Care FreeStyle. |
>Page 2 |
||||||||||
| Problem: Risk of overestimation of blood glucose results when these meters are used on samples from patients on treatments that contain (or are metabolised to) maltose, xylose or galactose. This problem does not apply to treatments taken orally. This alert updates and supersedes MDA/2003/011. |
>Page 2 |
||||||||||
|
Action by:
|
|
||||||||||
|
Action: If you are unsure if a particular patient treatment contains (or is metabolised to) maltose, xylose or galactose consult the medicines information department of your local hospital pharmacy. Telephone numbers for other medicines information services are listed in the British National Formulary (BNF). |
>Page 2 |
||||||||||
|
Distributed to:
* via CE Bulletin |
>Page 3 |
||||||||||
| Contacts: Details of manufacturer contacts and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for CSCI and Healthcare Commission. |
>Pages 3-4 |
|
Action deadlines for the Safety Alert Broadcast System (SABS)
|
|
|
Deadline (action underway): 16 August 2007
|
Deadline (action complete): 11 October 2007
|
MDA/2007/058 - Point of care and home-use blood glucose meters: Roche Accu-Chek and Glucotrend; Abbott Diabetes Care FreeStyle 
